Iovance Biotherapeutics: H.C. Wainwright raises target price to $20 from $9
IOVA•H.C. Wainwright raised its target price for Iovance Biotherapeutics to $20 from $9.
Related News
CPKC schedules release of third-quarter 2026 results after market close
CP•
Spotify, Anthropic's Claude down for some US users, Downdetector shows
SPOT•
Goldman Sachs drops below 5% stake in Forvia, holds 4.21% voting rights
GS•
CarMax's quarterly profit, revenue rise as pricing boosts used-car sales
KMX•
Trump to host Anthropic's Amodei, Nvidia's Huang and other executives as AI fears mount
QQQ•